Naproxen and cromolyn as new glycogen synthase kinase 3β inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation (Q42710614)
Jump to navigation
Jump to search
scientific article published on 19 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Naproxen and cromolyn as new glycogen synthase kinase 3β inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation |
scientific article published on 19 June 2013 |
Statements
1 reference
Naproxen and cromolyn as new glycogen synthase kinase 3β inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation (English)
1 reference
Tarek M K Motawi
1 reference
Yasser Bustanji
1 reference
Shohda A El-Maraghy
1 reference
Mutasem O Taha
1 reference
Mohamed A S Al Ghussein
1 reference
19 June 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference